Internal Medicine, Gastroenterology · Boston, MA
NPI
1336194752
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
75 Francis St
Boston, MA, 02115
Phone (617) 732-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
237 services
Medicare patients, 2024
121
Average age 72
Drug cost, 2024
$4.3M
579 prescriptions
Company payments, 2024
$30.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua Raphael Korzenik was code 99214 (office e&m - established), 198 times for 114 patients. In total Joshua Raphael Korzenik billed 237 services in 10 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 198 | 114 | $86.59 | $17K |
| 45380 Lower GI Endoscopy - Other | Office | 20 | 20 | $104.14 | $2,083 |
By year: 2022 $36K for 395 services; 2023 $20K for 251 services; 2024 $21K for 237 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua Raphael Korzenik prescribed most often to Medicare patients was Stelara (Ustekinumab), with 60 prescriptions and refills. In total Joshua Raphael Korzenik wrote 579 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 60 | 74 | Under 11 | $1.6M |
| Mesalamine Generic | 47 | 79 | Under 11 | $20K |
| Skyrizi On-Body Risankizumab-Rzaa | 42 | 66 | 12 | $835K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 35 | 36 | Under 11 | $1,089 |
| Famotidine Generic | 25 | 55 | Under 11 | $3,053 |
| Humira(Cf) Pen Adalimumab | 20 | 20 | Under 11 | $230K |
| Gabapentin Generic | 17 | 23 | Under 11 | $261 |
| Vancomycin Hcl Generic | 17 | 17 | 13 | $5,461 |
| Cimzia (2 Pack) Certolizumab Pegol | 15 | 15 | Under 11 | $86K |
| Mercaptopurine Generic | 15 | 33 | Under 11 | $788 |
| Trazodone Hcl Generic | 14 | 14 | Under 11 | $35.46 |
| Rinvoq Upadacitinib | 13 | 13 | Under 11 | $92K |
| Entyvio Vedolizumab | 12 | 12 | Under 11 | $109K |
| Gattex Teduglutide | 12 | 12 | Under 11 | $1.1M |
| Opium Tincture Generic | 12 | 12 | Under 11 | $6,766 |
Brand drugs: 257 claims; generic drugs: 309 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Joshua Raphael Korzenik $30.4 ($30.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $30.4.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $30.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.